DMAC Q1 2026 Earnings WiderthanExpected Loss as Clinical Development Costs Persist ZVIA Q1 2026 Earnings NarrowerThanExpected Loss Drives DoubleDigit Stock Gain ICHR Q1 2026 Earnings EPS Surpasses Expectations Stock Rises SLP Q1 2026 Earnings EPS Surpasses Estimates as Simulations Plus Posts 103 Beat STZ Q1 2026 Earnings EPS Surprise Beats Estimates Despite Flat Revenue Disclosure BNR Q3 2022 Earnings Narrower Loss Surpasses Estimates Stock Declines CAE Q1 2026 Earnings EPS Beats Estimates Stock Drops Over 14 Contineum Therapeutics Inc CTNM Q1 2026 Earnings ClinicalStage Biotech Reports Narrower Loss Shares Dip Teads Holding Co TEAD Q1 2026 Earnings EPS Surprises Positively but Stock Falters Novartis Q1 2026 Earnings EPS Falls Short of Estimates by 852 Stock Edges Higher IMRX Q1 2026 Earnings EPS Beat Estimates by 183 as Clinical Pipeline Advances PFXNZ Q1 2026 Earnings EPS Surges Past Estimates by 254 Amid Strong Portfolio Performance